Risk factors and management of intra-abdominal infection after extended radical gastrectomy

被引:38
作者
Lo, Chih-Hsien
Chen, Jen-Hao
Wu, Chew-Wun
Lo, Su-Shun [1 ]
Hsieh, Mao-Chih
Lui, Wing-Yiu
机构
[1] Taipei Vet Gen Hosp, Div Gen Surg, Taipei 112, Taiwan
关键词
Complications; Extended radical gastrectomy; Gastric cancer; Intra-abdominal infection; Risk factors;
D O I
10.1016/j.amjsurg.2007.11.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: This study elucidated risk factors and management for intra-abdominal infection after extended radical gastrectomy. METHODS: From 1988 to 2004, 2,076 patients with gastric cancer underwent extended radical gastrectomy at Taipei Veterans General Hospital. Risk factors for intra-abdominal infection were determined by analyzing clinicopathological factors, operative procedure, combined organ resection, operative time, blood loss, and associated disease(s). Management modalities were summarized. RESULTS: The overall complication rate was 18.7%. Eighty (3.9%) patients were found to have intra-abdominal infections. Age, prolonged operation time, and combined organ resection were the precipitating factors. These patients were categorized into 3 groups: intra-abdominal abscess with adequate drainage, intra-abdominal abscess without anastomotic leakage, and intra-abdominal abscess because of leakage. Adequate drainage was the primary treatment. Mortality rate was 22.5% (18), and the most common cause of mortality was intra-abdominal abscess caused by leakage. CONCLUSIONS: Although expert surgical skills can minimize the incidence of intra-abdominal infection, management also requires experience and training. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:741 / 745
页数:5
相关论文
共 26 条
[1]  
Arai K, 1994, Nihon Geka Gakkai Zasshi, V95, P56
[2]   RANDOMIZED COMPARISON OF MORBIDITY AFTER D1 AND D2 DISSECTION FOR GASTRIC-CANCER IN 996 DUTCH PATIENTS [J].
BONENKAMP, JJ ;
SONGUN, I ;
HERMANS, J ;
SASAKO, M ;
WELVAART, K ;
PLUKKER, JTM ;
VANELK, P ;
OBERTOP, H ;
GOUMA, DJ ;
TAAT, CW ;
VANLANSCHOT, J ;
MEYER, S ;
DEGRAAF, PW ;
VONMEYENFELDT, MF ;
TILANUS, H ;
VANDEVELDE, CJH .
LANCET, 1995, 345 (8952) :745-748
[3]   Extended lymph-node dissection for gastric cancer [J].
Bonenkamp, JJ ;
Hermans, J ;
Sasako, M ;
van de Velde, CJH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914
[4]   Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].
Cuschieri, A ;
Fayers, P ;
Fielding, J ;
Craven, J ;
Bancewicz, J ;
Joypaul, V ;
Cook, P .
LANCET, 1996, 347 (9007) :995-999
[5]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[6]   Preoperative serum albumin level as a predictor of operative mortality and morbidity - Results from the national VA surgical risk study [J].
Gibbs, J ;
Cull, W ;
Henderson, W ;
Daley, J ;
Hur, K ;
Khuri, SF .
ARCHIVES OF SURGERY, 1999, 134 (01) :36-42
[7]   Association of serum albumin and mortality risk [J].
Goldwasser, P ;
Feldman, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :693-703
[8]   Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial [J].
Hartgrink, HH ;
van de Velde, CJH ;
Putter, H ;
Bonenkamp, JJ ;
Kranenbarg, EK ;
Songun, I ;
Welvaart, K ;
van Krieken, JHJM ;
Meijer, S ;
Plukker, JTM ;
van Elk, PJ ;
Obertop, H ;
Gouma, DJ ;
van Lanschot, JJB ;
Taat, CW ;
de Graaf, PW ;
von Meyenfeldt, MF ;
Tilanus, H ;
Sasako, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2069-2077
[9]   No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer [J].
Kitamura, K ;
Nishida, S ;
Ichikawa, D ;
Taniguchi, H ;
Hagiwara, A ;
Yamaguchi, T ;
Sawai, K .
BRITISH JOURNAL OF SURGERY, 1999, 86 (01) :119-122
[10]  
Kitamura K, 1999, HEPATO-GASTROENTEROL, V46, P2074